News
Rampant bird flu has torn across America’s livestock, sickened farm workers and resulted in the culling of millions of birds ...
YONGIN, South Korea, April 9, 2025 /PRNewswire/ -- GC Biopharma announced 09. Apr. 2025 that the Korean Ministry of Food and Drug Safety (MFDS) has approved its anthrax vaccine, BARYTHRAX, jointly ...
It makes sense to include routine adult vaccinations to our list of preventative measures, not only for prevention of common ...
titers are significantly higher than those of currently marketed recombinant subunit control vaccines. Compared to similar products using the mRNA technology route, AIM's mRNA shingles vaccine also ...
The study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).
In February 2024, dairy farmers in Texas began noticing their cows were producing less milk and that the milk was discoloured ...
Desentum Oy, a clinical-stage biopharmaceutical company developing novel immunotherapies for treating allergies, announces positive clinical data with birch pollen allergy vaccine DM-101PX. The ...
Researchers are developing effective and safe ASF vaccines using various methods, but the classical approach faces challenges in generating recombinant ... from fluorescent images and performed ...
This study provides proof-of-principle data for the use of trained immunity to modulate macrophage interactions with tumours. The study makes a valuable contribution to the field of trained immunity.
Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are designed to be administered using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results